Neonatal Hyperthyroidism and Long-acting Thyroid Stimulator Protector
Authors:
- J. NuttJNJ. Nutt
- F. ClarkFCF. Clark
- R. G. WelchRWR. G. Welch
- R. HallRHR. Hall
Abstract
Neonatal hyperthyroidism has been thought to result from transplacental passage of long-acting thyroid stimulator (L.A.T.S.) from a mother with Graves's disease. A case is presented here in which no L.A.T.S. was detected in the mother or neonate but another immunoglobulin, L.A.T.S. protector, a specific human thyroid stimulator, was shown to be present in the mother's serum. This stimulator may have been the cause of the neonatal hyperthyroidism.Keywords
This publication has 11 references indexed in Scilit:
- Grades of HypothyroidismBMJ, 1973
- Direct Evidence for Human Thyroidal Stimulation by LATS-ProtectorThe Journal of Clinical Endocrinology & Metabolism, 1973
- Graves' disease--1972.1972
- Does lats cause hyperthyroidism in Graves' disease?Metabolism, 1972
- Evidence To Suggest That LATS Protector Stimulates the Human Thyroid GlandThe Journal of Clinical Endocrinology & Metabolism, 1971
- THYROTROPHIN-RELEASING HORMONE AS A THYROID-FUNCTION TESTThe Lancet, 1971
- Radioimmunoassay of Human Serum ThyrotrophinBMJ, 1971
- THE INTERACTION OF THE LONG-ACTING THYROID STIMULATOR (LATS) WITH THYROID TISSUE IN VITROJournal of Endocrinology, 1970
- Occurrence in Thyrotoxicosis of a Gamma Globulin Which Protects LATS from Neutralization by an Extract of Thyroid GlandThe Journal of Clinical Endocrinology & Metabolism, 1967
- NEONATAL THYROTOXICOSIS ASSOCIATED WITH MATERNAL HYPOTHYROIDISMThe Lancet, 1966